These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 15343336

  • 1. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.
    Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE.
    Nature; 2004 Sep 02; 431(7004):84-7. PubMed ID: 15343336
    [Abstract] [Full Text] [Related]

  • 2. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G, Correia-Neves M, Buteme H, Hamasur B, Svenson SB.
    Tuberculosis (Edinb); 2016 Jan 02; 96():120-30. PubMed ID: 26586646
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles.
    Krishnan N, Malaga W, Constant P, Caws M, Tran TH, Salmons J, Nguyen TN, Nguyen DB, Daffé M, Young DB, Robertson BD, Guilhot C, Thwaites GE.
    PLoS One; 2011 Jan 02; 6(9):e23870. PubMed ID: 21931620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.
    Blanc L, Gilleron M, Prandi J, Song OR, Jang MS, Gicquel B, Drocourt D, Neyrolles O, Brodin P, Tiraby G, Vercellone A, Nigou J.
    Proc Natl Acad Sci U S A; 2017 Oct 17; 114(42):11205-11210. PubMed ID: 28973928
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ipr1 gene mediates innate immunity to tuberculosis.
    Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, Higgins DE, Daly MJ, Bloom BR, Kramnik I.
    Nature; 2005 Apr 07; 434(7034):767-72. PubMed ID: 15815631
    [Abstract] [Full Text] [Related]

  • 13. [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence].
    Fujiwara N.
    Kekkaku; 1997 Apr 07; 72(4):193-205. PubMed ID: 9145649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.
    Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM.
    Nat Immunol; 2010 Aug 07; 11(8):751-8. PubMed ID: 20622882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
    Rao V, Gao F, Chen B, Jacobs WR, Glickman MS.
    J Clin Invest; 2006 Jun 07; 116(6):1660-7. PubMed ID: 16741578
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.